You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 157 No. 6, 24 MARCH 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL OBSERVATION
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Elevation of Serum Creatine Kinase During Treatment With Antithyroid Drugs in Patients With Hyperthyroidism Due to Graves Disease

A Novel Side Effect of Antithyroid Drugs

Satoru Suzuki, MD; Kazuo Ichikawa, MD; Minoru Nagai, MD; Michiaki Mikoshiba, MD; Jun-ichiro Mori, MD; Atsuko Kaneko, MD; Rieko Sekine, MD; Nahoko Asanuma, MD; Masahiro Hara, MD; Yutaka Nishii, MD; Keishi Yamauchi, MD; Toru Aizawa, MD; Kiyoshi Hashizume, MD

Arch Intern Med. 1997;157(6):693-696.


Abstract

We describe 4 patients with Graves disease who had abnormal increases of serum creatine kinase (CK) concentrations during treatment with antithyroid medications. Three of the patients experienced myalgia and muscle cramps. All of the patients manifested an increase in serum CK levels 1 to 3 months after the administration of antithyroid drugs. Thyrotropin concentrations and cardiac systolic time indexes during the elevation of serum CK concentrations were not consistent with hypothyroidism. The mechanisms are not obvious, but it is likely that the rapid decrease of thyroid hormones in tissues may temporarily cause hypothyroid states, resulting in alterations in CK concentrations. It is suggested that hasty correction of thyrotoxicosis should be avoided in susceptible patients, unless the thyrotoxic conditions are critical.

Arch Intern Med. 1997;157:693-696



Author Affiliations

From the Department of Geriatrics, Shinshu University School of Medicine, Matsumoto, Japan.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.